Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Share-based Compensation (2022 - 2025)

Historic Share-based Compensation for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $6.7 million.

  • Prokidney's Share-based Compensation fell 373.52% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year increase of 6558.06%. This contributed to the annual value of $29.4 million for FY2024, which is 477.86% down from last year.
  • As of Q3 2025, Prokidney's Share-based Compensation stood at $6.7 million, which was down 373.52% from $6.5 million recorded in Q2 2025.
  • Prokidney's 5-year Share-based Compensation high stood at $52.7 million for Q1 2022, and its period low was -$6.4 million during Q4 2023.
  • Over the past 4 years, Prokidney's median Share-based Compensation value was $7.7 million (recorded in 2024), while the average stood at $10.3 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 17125.28% in 2023, then surged by 20907.38% in 2024.
  • Over the past 4 years, Prokidney's Share-based Compensation (Quarter) stood at $8.9 million in 2022, then crashed by 171.25% to -$6.4 million in 2023, then soared by 209.07% to $6.9 million in 2024, then fell by 3.93% to $6.7 million in 2025.
  • Its last three reported values are $6.7 million in Q3 2025, $6.5 million for Q2 2025, and $6.4 million during Q1 2025.